ReviewDrug and alcohol dependence reports2025
Utility of substance-free alternatives in treating and preventing harmful substance use: A narrative review of the translational research spectrum.
Review in Drug and alcohol dependence reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Behavioral economic demand for ethanol in Long Evans rats: Influence of choice context, sex, and vapor history.Psychopharmacology · 2026Article
- Chronic ethanol vapor exposure suppresses ethanol self-administration and behavioral allocation in a concurrent operant choice paradigm in male and female Long Evans rats.Psychopharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interventions primarily focused on constraining access to substances have largely failed to reduce substance use and associated harms. Alternative approaches informed by behavioral theories of choice focus on reducing harmful substance use by increasing access to and engagement in substance-free rewards that can compete with substance use. This narrative review of the translational research spectrum, organized by research phases in the Food and Drug Administration's Drug Approval Process, summarizes wide-ranging research on associations between substance-free alternatives (palatable stimuli, money, social interaction, physical activity) and substance use and related harms. Studies reviewed span laboratory experiments with nonhuman animals to human experiments and treatment and prevention research. With limited exceptions, research across the translational spectrum supported the role of substance-free alternative rewards in reducing harmful substance use. Effective substitutes for substance use under specific conditions included palatable stimuli in animal studies and monetary incentives and social interaction opportunities with non-substance using peers in human studies. Evidence for physical activity was mixed, with stronger support found in animal than human research. Emerging research further suggests that increasing access to substance-free activities in broader socioecological contexts surrounding harmful use (e.g., communities, drug-related policy) also are needed. Increasing access to substance-free rewards through individual- and community-level interventions is a promising alternative to conventional approaches that primarily focus on reducing substance use and related negative consequences by constraining access to substances. Community-level and public health policy efforts guided by behavioral theories of choice merit further development and evaluation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.